Article · 29 Dec 2023
Research articlePublished 21 Dec 2019
RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF CEFTALAZONE AND TAZOBACTUM IN BULK AND IN ITS PHARMACEUTICAL DOSAGE FORMS
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A validated RP-HPLC method was developed for simultaneous estimation of Ceftalazone and Tazobactam in bulk and in its pharmaceutical dosage form. The current method is simple, precise, and accurate and can be used for the quantification in the regular quality control tests and in industries. The optimization of the method was done by using several combinations of mobile phases and different columns and finally the chromatograms showed good resolution, retention time, peak response and lowest noise base line ratio by using Acetonitrile and phosphate buffer of pH 4 at a ratio of 70:30%v/v at a wavelength of 234nm using UV detector for detection. The retention time of Ceftalazone and Tazobactum was found to be 2.42 & 4.42 at a flow rate of 1ml/min. The current method was validated for accuracy, % assay, precision, Linearity, LOD and LOQ. The % assay of Ceftalazone and Tazobactum was found to be 101.3% and 101.8%. The linearity shown by the drugs at a concentration range of 50-150ppm of Ceftalazone and 25-75 ppm of Tazobactum showing regression co-efficient of 0.999, respectively. The LOD of Ceftalazone & Tazobactum was found to be 1.46 and 4.45 and LOQ was found to be 0.47 and 1.42, respectively. The current newly developed method was validated as per the ICH guidelines.
Keywords
Subjects
Pharmaceutical SciencesChemistryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Chemical and Pharmaceutical Analysis.
Perspective · 4 Oct 2022
NEED OF HYALURONIDASE TREATMENT FOR ACCURATE IDENTIFICATION OF INFLAMMATORY CELLS AND SOLUBLE MEDIATORS
Perspective · 4 Oct 2022
NANOMEDICINE: AN ENABLING TOOL IN THE MODERN PHARMACEUTICAL FIELD
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Chemical and Pharmaceutical Analysis
- SubjectPharmaceutical Sciences
- SubjectChemistry
- BylineArticles whose byline prints “Kandala Neela Maneesha”
- BylineArticles whose byline prints “Namratha Sunkara”
- BylineArticles whose byline prints “Sanapala Arun Kumar”
- BylineArticles whose byline prints “P. Rama Lakshmi”